From discovery through emergency use to the present: Safety evaluation of the COVID-19 mRNA-1273 (Moderna) vaccine. [PDF]
Straus W.
europepmc +1 more source
Evaluation of Cardiac Troponin Levels in Individuals Aged 12-30 Years Following mRNA-1273 Vaccination: Results From a Randomized Placebo-Controlled Trial. [PDF]
Pfeiffer S +8 more
europepmc +1 more source
Longitudinal evaluation of anti-SARS-CoV-2 neutralizing antibody levels in 3-dose homologous (mRNA-1273- mRNA-1273- BNT162b2) vaccinated kidney transplant population: 18-month follow-up. [PDF]
Karunathilake KRP +9 more
europepmc +1 more source
Contactin-1-Associated Membranous Nephropathy after Multiple mRNA 1273 COVID-19 Vaccinations: A Case Report. [PDF]
Zuckerman JE, Sisk A, Copen EP, Copen S.
europepmc +1 more source
IgG4 Neutralization and Sustained Total IgG Fc-Effector Functions Following Repeated SARS-CoV-2 Vaccination with mRNA-1273. [PDF]
Kaplonek P +10 more
europepmc +1 more source
A Reanalysis of the FDA's Benefit-Risk Assessment of Moderna's mRNA-1273 COVID Vaccine Based on a Model Incorporating Benefits Derived from Prior COVID Infection. [PDF]
Bourdon PS +5 more
europepmc +1 more source
Comparative Effectiveness of mRNA-1273 Versus Protein-Based NVX-CoV2705 Vaccination on COVID-19-Related Outcomes Among Insured Adults in the United States During 2024-2025: A Retrospective Matched Cohort Study. [PDF]
Wilson A +8 more
europepmc +1 more source
Short-term mycophenolic acid withdrawal is associated with temporal changes in immune cell composition in mRNA-1273-vaccinated kidney transplant recipients: insights from high-dimensional immune profiling. [PDF]
Goerlich N +11 more
europepmc +1 more source
What is already known about this topic? Studies have found an increased risk for cardiac Complications after SARS-CoV-2 infection and mRNA COVID-19 vaccination, but few have compared these risks.What is added by this report?
core
Extreme PTH-Independent Hypercalcemia Mediated by a Rare Non-Osteoclastic Osteolysis Mechanism in Newly Diagnosed High-Risk Biclonal IgA Multiple Myeloma: Temporal Association with the Second Dose of Moderna mRNA-1273 COVID-19 Vaccine. [PDF]
Finch-Cruz CN +2 more
europepmc +1 more source

